<?xml version="1.0" encoding="ISO-8859-1"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://ecam.oxfordjournals.org">
<title>Evidence-based Complementary and Alternative Medicine - recent issues</title>
<link>http://ecam.oxfordjournals.org</link>
<description>Evidence-based Complementary and Alternative Medicine - RSS feed of recent issues (covers the latest 3 issues, including the current issue) </description>
<prism:eIssn>1741-4288</prism:eIssn>
<prism:publicationName>Evidence-based Complementary and Alternative Medicine</prism:publicationName>
<prism:issn>1741-427X</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/1/1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/1/3?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/1/17?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/1/27?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/1/37?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/1/41?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/1/51?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/1/55?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/1/61?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/1/71?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/1/77?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/1/85?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/1/91?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/1/95?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/1/103?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/1/107?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/1/115?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/1/117?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/1/119?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/4/4/399?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/4/4/401?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/4/4/409?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/4/4/419?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/4/4/425?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/4/4/431?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/4/4/439?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/4/4/447?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/4/4/455?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/4/4/463?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/4/4/469?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/4/4/487?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/4/4/493?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/4/4/503?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/4/4/511?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/4/4/519?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/4/suppl_1/1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/4/suppl_1/3?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/4/suppl_1/5?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/4/suppl_1/9?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/4/suppl_1/13?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/4/suppl_1/17?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/4/suppl_1/21?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/4/suppl_1/25?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/4/suppl_1/29?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/4/suppl_1/33?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/4/suppl_1/37?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/4/suppl_1/41?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/4/suppl_1/45?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/4/suppl_1/53?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/4/suppl_1/55?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/4/suppl_1/59?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/4/suppl_1/65?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/4/suppl_1/69?rss=1" />
 </rdf:Seq>
</items>
</channel>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/1/1?rss=1">
<title><![CDATA[Ayurveda is Embraced by eCAM]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/1/1?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Cooper, E. L.]]></dc:creator>
<dc:date>2008-02-21</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen016</dc:identifier>
<dc:title><![CDATA[Ayurveda is Embraced by eCAM]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>2</prism:endingPage>
<prism:publicationDate>2008-03-01</prism:publicationDate>
<prism:startingPage>1</prism:startingPage>
<prism:section>Editorial</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/1/3?rss=1">
<title><![CDATA[The Medicinal Mushroom Agaricus blazei Murrill: Review of Literature and Pharmaco-Toxicological Problems]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/1/3?rss=1</link>
<description><![CDATA[
<p><I>Agaricus blazei</I> Murrill (ABM) popularly known as &lsquo;<I>Cogumelo do Sol</I>&rsquo; in Brazil, or &lsquo;<I>Himematsutake</I>&rsquo; in Japan, is a mushroom native to Brazil, and widely cultivated in Japan for its medicinal uses, so it is now considered as one of the most important edible and culinary-medicinal biotechnological species. It was traditionally used to treat many common diseases like atherosclerosis, hepatitis, hyperlipidemia, diabetes, dermatitis and cancer. <I>In vitro</I> and <I>in vivo</I> ABM has shown immunomodulatory and antimutagenic properties, although the biological pathways and chemical substances involved in its pharmacological activities are still not clear. The polysaccharides phytocomplex is thought to be responsible for its immunostimulant and antitumor properties, probably through an opsonizing biochemical pathway. Clinical studies are positive confirmations, but we are still at the beginning, and there are perplexing concerns especially relative to the content of agaritine. Argantine is a well-known carcinogenic and toxic substance in animals, that must be completely and fully evaluated.</p>
]]></description>
<dc:creator><![CDATA[Firenzuoli, F., Gori, L., Lombardo, G.]]></dc:creator>
<dc:date>2008-02-21</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem007</dc:identifier>
<dc:title><![CDATA[The Medicinal Mushroom Agaricus blazei Murrill: Review of Literature and Pharmaco-Toxicological Problems]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>15</prism:endingPage>
<prism:publicationDate>2008-03-01</prism:publicationDate>
<prism:startingPage>3</prism:startingPage>
<prism:section>Reviews</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/1/17?rss=1">
<title><![CDATA[The Life Threatened Child and the Life Enhancing Clown: Towards a Model of Therapeutic Clowning]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/1/17?rss=1</link>
<description><![CDATA[
<p>In the last decade, there has been a rapid growth in the presence of clowns in hospitals, particularly in pediatric settings. The proliferation of clowns in health care settings has resulted in varying levels of professionalism and accountability. For this reason, there is a need to examine various forms of clowning, in particular therapeutic clowning in pediatric settings. The purpose of this article is to address what therapeutic clowning is and to describe the extent to which it can provide a complementary form of health care. In an attempt to apply theory to practice, the article will draw upon the experiences of a therapeutic clown within a pediatric setting while providing a historical and theoretical account of how clowns came to be in hospitals. Toward this end, a proposed model of therapeutic clowning will be offered which can be adapted for a variety of settings where children require specialized forms of play in order to enhance their coping, development and adjustment to life changes. Finally, current research on clowning in children's hospitals will be reviewed including a summary of findings from surveys administered at the Hospital for Sick Children.</p>
]]></description>
<dc:creator><![CDATA[Koller, D., Gryski, C.]]></dc:creator>
<dc:date>2008-02-21</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem033</dc:identifier>
<dc:title><![CDATA[The Life Threatened Child and the Life Enhancing Clown: Towards a Model of Therapeutic Clowning]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>25</prism:endingPage>
<prism:publicationDate>2008-03-01</prism:publicationDate>
<prism:startingPage>17</prism:startingPage>
<prism:section>Reviews</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/1/27?rss=1">
<title><![CDATA[The Treatment of Pulmonary Diseases and Respiratory-Related Conditions with Inhaled (Nebulized or Aerosolized) Glutathione]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/1/27?rss=1</link>
<description><![CDATA[
<p>Reduced glutathione or simply glutathione (-glutamylcysteinylglycine; GSH) is found in the cytosol of most cells of the body. GSH in the epithelial lining fluid (ELF) of the lower respiratory tract is thought to be the first line of defense against oxidative stress. Inhalation (nebulized or aerosolized) is the only known method that increases GSH's levels in the ELF. A review of the literature was conducted to examine the clinical effectiveness of inhaled GSH as a treatment for various pulmonary diseases and respiratory-related conditions. This report also discusses clinical and theoretical indications for GSH inhalation, potential concerns with this treatment, its presumed mechanisms of action, optimal doses to be administered and other important details. Reasons for inhaled GSH's effectiveness include its role as a potent antioxidant, and possibly improved oxygenation and host defenses. Theoretical uses of this treatment include Farmer's lung, pre- and postexercise, multiple chemical sensitivity disorder and cigarette smoking. GSH inhalation should not be used as a treatment for primary lung cancer. Testing for sulfites in the urine is recommended prior to GSH inhalation. Minor side effects such as transient coughing and an unpleasant odor are common with this treatment. Major side effects such as bronchoconstriction have only occurred among asthma patients presumed to be sulfite-sensitive. The potential applications of inhaled GSH are numerous when one considers just how many pulmonary diseases and respiratory-related conditions are affected by deficient antioxidant status or an over production of oxidants, poor oxygenation and/or impaired host defenses. More studies are clearly warranted.</p>
]]></description>
<dc:creator><![CDATA[Prousky, J.]]></dc:creator>
<dc:date>2008-02-21</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem040</dc:identifier>
<dc:title><![CDATA[The Treatment of Pulmonary Diseases and Respiratory-Related Conditions with Inhaled (Nebulized or Aerosolized) Glutathione]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>35</prism:endingPage>
<prism:publicationDate>2008-03-01</prism:publicationDate>
<prism:startingPage>27</prism:startingPage>
<prism:section>Reviews</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/1/37?rss=1">
<title><![CDATA[Humor and Laughter May Influence Health: III. Laughter and Health Outcomes]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/1/37?rss=1</link>
<description><![CDATA[
<p>This is part three of a four-part series reviewing the evidence on how humor influences physiological and psychological well-being. The first article included basic background information, definitions and a review of the theoretical underpinnings for this area of research. The second article discussed use of humor as a complementary therapy within various clinical samples, as well as evidence concerning how a sense of humor influences physiological and psychological wellbeing. This third article examines how laughter influences health outcomes; including muscle tension, cardio-respiratory functioning and various stress physiology measures.</p>
]]></description>
<dc:creator><![CDATA[Bennett, M. P., Lengacher, C.]]></dc:creator>
<dc:date>2008-02-21</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem041</dc:identifier>
<dc:title><![CDATA[Humor and Laughter May Influence Health: III. Laughter and Health Outcomes]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>40</prism:endingPage>
<prism:publicationDate>2008-03-01</prism:publicationDate>
<prism:startingPage>37</prism:startingPage>
<prism:section>Reviews</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/1/41?rss=1">
<title><![CDATA[Mind/Body Psychological Treatments for Irritable Bowel Syndrome]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/1/41?rss=1</link>
<description><![CDATA[
<p>Currently, the goal of treatment for those with irritable bowel syndrome (IBS) is to improve the quality of life through a reduction in symptoms. While the majority of treatment approaches involve the use of traditional medicine, more and more patients seek out a non-drug approach to managing their symptoms. Current forms of non-drug psychologic or mind/body treatment for IBS include hypnotherapy, cognitive behavioral therapy and brief psychodynamic psychotherapy, all of which have been proven efficacious in clinical trials. We propose that incorporating the constructs of mindfulness and acceptance into a mind/body psychologic treatment of IBS may be of added benefit due to the focus on changing awareness and acceptance of one's own state which is a strong component of traditional and Eastern healing philosophies.</p>
]]></description>
<dc:creator><![CDATA[Naliboff, B. D., Frese, M. P., Rapgay, L.]]></dc:creator>
<dc:date>2008-02-21</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem046</dc:identifier>
<dc:title><![CDATA[Mind/Body Psychological Treatments for Irritable Bowel Syndrome]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>50</prism:endingPage>
<prism:publicationDate>2008-03-01</prism:publicationDate>
<prism:startingPage>41</prism:startingPage>
<prism:section>Reviews</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/1/51?rss=1">
<title><![CDATA[First International Conference between West and East--Leonardo and Lao-Tze. Western Science Meets Eastern Wisdom. Experiences of Scientists and Intellectuals for the Creation of a New Paradigm of Modern Science]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/1/51?rss=1</link>
<description><![CDATA[
<p>The <I>Conference</I> was organized and supported by: <I>Nei Dan School</I> (European School of Internal Martial Arts), <I>NIB</I> (Laboratory of Molecular Biology and Stem Cell Bioengineering, National Institute of Biostructures and Biosystems, Institute of Cardiology, S.Orsola-Malpighi Hospital, Bologna), <I>WACIMA</I> (Worldwide Association Chinese Internal Martial Arts), <I>Arti D&rsquo;Oriente</I> <b>(</b>Magazine of Eastern culture and traditions), <I>Nuovo Orizzonte</I> (Taiji Quan School in Florence), <I>Samurai</I> (Journal on Martial Arts), and <I>Pinus</I> (First National Institute for the Unification of Medical Strategies). Nei Dan School (<inter-ref locator="www.taichineidan.com" locator-type="url">www.taichineidan.com</inter-ref>,  <inter-ref locator="neidan@libero.it" locator-type="email">neidan@libero.it</inter-ref>) was in charge of the organization. Future meetings of the Centro studi &lsquo;Tao and Science&rsquo; will take place in spring 2007 in Firenze and in October 2007 in Bologna. For information: E-mail:  <inter-ref locator="neidan@libero.it" locator-type="email">neidan@libero.it</inter-ref>; web site: <inter-ref locator="www.taichineidan.com" locator-type="url">www.taichineidan.com</inter-ref>, <inter-ref locator="www.taoandscience.com" locator-type="url">www.taoandscience.com</inter-ref></p>
]]></description>
<dc:creator><![CDATA[Daniele, F.]]></dc:creator>
<dc:date>2008-02-21</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem039</dc:identifier>
<dc:title><![CDATA[First International Conference between West and East--Leonardo and Lao-Tze. Western Science Meets Eastern Wisdom. Experiences of Scientists and Intellectuals for the Creation of a New Paradigm of Modern Science]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>54</prism:endingPage>
<prism:publicationDate>2008-03-01</prism:publicationDate>
<prism:startingPage>51</prism:startingPage>
<prism:section>Commentary</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/1/55?rss=1">
<title><![CDATA[Inhibitory Response of Raphanus sativus on Lipid Peroxidation in Albino Rats]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/1/55?rss=1</link>
<description><![CDATA[
<p>In the present study, inhibitory effect of the methanol extract of <I>Raphanus sativus</I> root on lipid peroxidation has been carried out in normal rats. Graded doses of methanol extract of root of the plant (40, 80 and 120 mg kg<sup>&ndash;1</sup> body weight) were administered orally for 15 days to experimental treated rats. Distilled water was administered to experimental control rats. At the end of experiment, rats were killed by decapitation after ether anesthesia. Blood and liver were collected to measure thiobarbituric acid reactive substance, reduced glutathione and activity of catalase. Results indicated that the extract of <I>R. sativus</I> root reduced the levels of thiobarbituric acid reactive substance significantly in all experimental treated groups (<I>P</I> &lt; 0.05) as compared to the experimental control group. It also increased the levels of reduced glutathione and increased the activity of catalase. <I>In vitro</I> experiments with the liver of experimental control and experimental treated rats were also carried out against cumene hydroperoxide induced lipid peroxidation. The extract inhibited <I>in vitro</I> cumene hydroperoxide induced lipid peroxidation. <I>R. sativus</I> inhibits lipid peroxidation <I>in vivo</I> and <I>in vitro</I>. It provides protection by strengthening the antioxidants like glutathione and catalase. Inclusion of this plant in every day diet would be beneficial.</p>
]]></description>
<dc:creator><![CDATA[Chaturvedi, P.]]></dc:creator>
<dc:date>2008-02-21</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nel077</dc:identifier>
<dc:title><![CDATA[Inhibitory Response of Raphanus sativus on Lipid Peroxidation in Albino Rats]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>59</prism:endingPage>
<prism:publicationDate>2008-03-01</prism:publicationDate>
<prism:startingPage>55</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/1/61?rss=1">
<title><![CDATA[Oral Bromelain Attenuates Inflammation in an Ovalbumin-induced Murine Model of Asthma]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/1/61?rss=1</link>
<description><![CDATA[
<p>Bromelain, a widely used pineapple extract with cysteine protease activity, has been shown to have immunomodulatory effects in a variety of immune system models. The purpose of the present study was to determine the effects of orally administered bromelain in an ovalbumin (OVA)-induced murine model of acute allergic airway disease (AAD). To establish AAD, female C57BL/6J mice were sensitized with intraperitoneal (i.p.) OVA/alum and then challenged with OVA aerosols for 3 days. Mice were gavaged with either (phosphate buffered saline)PBS or 200 mg/kg bromelain in PBS, twice daily for four consecutive days, beginning 1 day prior to OVA aerosol challenge. Airway reactivity and methacholine sensitivity, bronchoalveolar lavage (BAL) cellular differential, Th2 cytokines IL-5 and IL-13, and lung histology were compared between treatment groups. Oral bromelain-treatment of AAD mice demonstrated therapeutic efficacy as evidenced by decreased methacholine sensitivity (<I>P</I> &le; 0.01), reduction in BAL eosinophils (<I>P</I> &le; 0.02) and IL-13 concentrations (<I>P</I> &le; 0.04) as compared with PBS controls. In addition, oral bromelain significantly reduced BAL CD19+ B cells (<I>P</I> &le; 0.0001) and CD8+ T cells (<I>P</I> &le; 0.0001) in AAD mice when compared with controls. These results suggest that oral treatment with bromelain had a beneficial therapeutic effect in this murine model of asthma and bromelain may also be effective in human conditions.</p>
]]></description>
<dc:creator><![CDATA[Secor, E. R., Carson, W. F., Singh, A., Pensa, M., Guernsey, L. A., Schramm, C. M., Thrall, R. S.]]></dc:creator>
<dc:date>2008-02-21</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nel110</dc:identifier>
<dc:title><![CDATA[Oral Bromelain Attenuates Inflammation in an Ovalbumin-induced Murine Model of Asthma]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>69</prism:endingPage>
<prism:publicationDate>2008-03-01</prism:publicationDate>
<prism:startingPage>61</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/1/71?rss=1">
<title><![CDATA[Green Brazilian Propolis Action on Macrophages and Lymphoid Organs of Chronically Stressed Mice]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/1/71?rss=1</link>
<description><![CDATA[
<p>Stress is a generic term that summarizes how psychosocial and environmental factors influence physical and mental well-being. The interaction between stress and immunity has been widely investigated, involving the neuroendocrine system and several organs. Assays using natural products in stress models deserve further investigation. Propolis immunomodulatory action has been mentioned and it has been the subject of scientific investigation in our laboratory. The aim of this study was to evaluate if and how propolis activated macrophages in BALB/c mice submitted to immobilization stress, as well as the histopathological analysis of the thymus, bone marrow, spleen and adrenal glands. Stressed mice showed a higher hydrogen peroxide (H<SUB>2</SUB>O<SUB>2</SUB>) generation by peritoneal macrophages, and propolis treatment potentiated H<SUB>2</SUB>O<SUB>2</SUB> generation and inhibited nitric oxide (NO) production by these cells. Histopathological analysis showed no alterations in the thymus, bone marrow and adrenal glands, but increased germinal centers in the spleen. Propolis treatment counteracted the alterations found in the spleen of stressed mice. New research is being carried out in order to elucidate propolis immunomodulatory action during stress.</p>
]]></description>
<dc:creator><![CDATA[Missima, F., Sforcin, J. M.]]></dc:creator>
<dc:date>2008-02-21</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nel112</dc:identifier>
<dc:title><![CDATA[Green Brazilian Propolis Action on Macrophages and Lymphoid Organs of Chronically Stressed Mice]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>75</prism:endingPage>
<prism:publicationDate>2008-03-01</prism:publicationDate>
<prism:startingPage>71</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/1/77?rss=1">
<title><![CDATA[Amelioration of Heat Stress Induced Disturbances of Antioxidant Defense System in Chicken by Brahma Rasayana]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/1/77?rss=1</link>
<description><![CDATA[
<p>Since the range of comfort zone or thermo neutral zone of domestic chickens is narrow, they become easily susceptible to heat and cold environmental stress. We evaluated Brahma Rasayana (BR) supplementation on concentrations of certain oxidative stress markers associated with heat stress. A total of 48 egg type male chickens of local strain were divided into six groups (<I>n</I> = 8) for the study. Three groups were fed with BR orally at the rate of 2 g/kg bw daily for 10 days prior to and during the period of experiment. Two of the four groups that were exposed to heat stress (HST i.e. to a temperature of 40 &plusmn; 1&deg;C and relative humidity of 80 &plusmn; 5% in an environmental chamber) for 4 h daily for 5 or 10 days, received BR orally. The other two groups remained as BR treated and untreated non-heat stressed (NHST) controls. There was a significant (<I>P</I> &lt; 0.05) increase in the activities of antioxidant enzymes in blood such as catalase (CAT) and superoxide dismutase (SOD), as well as liver CAT, glutathione peroxidase (GPX) and glutathione reductase (GR) in NHST-BR treated and HST-BR treated (both 5 and 10 days) chickens when compared with untreated controls. A great deal of significant (<I>P</I> &lt; 0.05) variations were seen in serum and liver reduced glutathione (GSH) concentration in NHST-BR treated and HST-BR treated (both 5 and 10 days) chickens. Serum and liver lipid peroxidation levels were found to be significantly (<I>P</I> &lt; 0.05) higher in HST-untreated (both 5 and 10 days) chickens when compared with other groups. Thus BR supplementation during HST brings about enhanced action of enzymatic and non-enzymatic antioxidants, which nullified the undesired side effects of free radicals that are generated during HST.</p>
]]></description>
<dc:creator><![CDATA[Ramnath, V., Rekha, P. S., Sujatha, K. S.]]></dc:creator>
<dc:date>2008-02-21</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nel116</dc:identifier>
<dc:title><![CDATA[Amelioration of Heat Stress Induced Disturbances of Antioxidant Defense System in Chicken by Brahma Rasayana]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>84</prism:endingPage>
<prism:publicationDate>2008-03-01</prism:publicationDate>
<prism:startingPage>77</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/1/85?rss=1">
<title><![CDATA[Phellinus linteus Extract Augments the Immune Response in Mitomycin C-Induced Immunodeficient Mice]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/1/85?rss=1</link>
<description><![CDATA[
<p><I>Phellinus linteus</I> is a fungus distributed throughout Japan, Korea and China. Boiled water-soluble extracts from <I>P. linteus</I> (PLW) have shown anti-tumor and immunomodulatory properties in experiments done by intraperitoneal treatment, or in <I>in vitro</I> cell cultures. This is the first investigation on how oral administration of PLW influences immune responses. Here, we established immunodeficient mice by mitomycin C (MMC) and then researched how PLW influenced plaque-forming cell (PFC) production and populations of cytokine [interferon- (IFN-) and interleukin-4 (IL-4)]-producing T lymphocytes. PLW samples were administered orally for 19 days (1, 2 or 4 g/kg/day). PFC assay was followed using Jerne's method. IFN- and IL-4-producing T lymphocyte populations were measured by flow-activated cell sorter (FACS). These assays were conducted the day after the last oral administration. MMC groups were given MMC (1 mg/kg/day) intraperitoneally for 6 days with PLW administration. The number of PFC per 10<sup>6</sup> spleen cells increased significantly in the PLW (2 g/kg/day) group when compared with the MMC-control (<I>P</I> <I>&lt;</I> 0.05) while populations of IFN- and IL-4-producing T lymphocytes decreased by MMC treatment. However, the PLW group tended to increase more than the MMC-control. Our results indicated that PLW augments the immune response of the spleen in MMC-induced immunodeficient mice.</p>
]]></description>
<dc:creator><![CDATA[Matsuba, S., Matsuno, H., Sakuma, M., Komatsu, Y.]]></dc:creator>
<dc:date>2008-02-21</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem001</dc:identifier>
<dc:title><![CDATA[Phellinus linteus Extract Augments the Immune Response in Mitomycin C-Induced Immunodeficient Mice]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>90</prism:endingPage>
<prism:publicationDate>2008-03-01</prism:publicationDate>
<prism:startingPage>85</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/1/91?rss=1">
<title><![CDATA[Post-Coital Antifertility Activity of Hibiscus rosa-sinensis Linn. roots]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/1/91?rss=1</link>
<description><![CDATA[
<p>Ancient literature mentions the use of a number of plants/preparations for fertility regulation. Some local contraceptive agents have also been described in Ayurvedic and Unani texts. Documented experiments or clinical data are, however, lacking. Therefore, the present study was undertaken to explore the antifertility and estrogenic activity of ethanolic extract of the roots of <I>Hibiscus rosa-sinensis</I> Linn. A strong anti-implantation (inhibition 100%) and uterotropic activity was observed at the dose level of 400 mg/kg body weight. Histological studies were carried out to confirm this effect.</p>
]]></description>
<dc:creator><![CDATA[Vasudeva, N., Sharma, S. K.]]></dc:creator>
<dc:date>2008-02-21</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem003</dc:identifier>
<dc:title><![CDATA[Post-Coital Antifertility Activity of Hibiscus rosa-sinensis Linn. roots]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>94</prism:endingPage>
<prism:publicationDate>2008-03-01</prism:publicationDate>
<prism:startingPage>91</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/1/95?rss=1">
<title><![CDATA[Evaluation of Antioxidant and Wound Healing Effects of Alcoholic and Aqueous Extract of Ocimum sanctum Linn in Rats]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/1/95?rss=1</link>
<description><![CDATA[
<p>In recent years, oxidative stress and free radicals have been implicated in impaired wound healing. <I>Ocimum sanctum</I> (<I>O. sanctum</I>), a plant widely used in Ayurveda, possesses anti-inflammatory and antioxidant properties. The present study was undertaken to assess the potential of alcoholic and aqueous extracts in wound healing in Wistar albino rats. The rats were divided into five groups of six animals each. Group 1 is normal wounded control and the other four groups were treated with two different doses each of alcoholic and aqueous extract of <I>O. sanctum</I>. The wound healing parameters were evaluated by using incision, excision and dead space wounds in extract-treated rats and controls. Both the doses of alcoholic and aqueous extract significantly increased wound breaking strength, hydroxyproline, hexuronic acid, hexosamines, superoxide dismutase, catalase, reduced glutathione and significantly decreased percentage of wound contraction and lipid peroxidation when compared with the control group. The results suggest that <I>O. sanctum</I> has antioxidant properties, which may be responsible and favorable for faster wound healing and this plant extract may be useful in the management of abnormal healing and hypertropic scars.</p>
]]></description>
<dc:creator><![CDATA[Shetty, S., Udupa, S., Udupa, L.]]></dc:creator>
<dc:date>2008-02-21</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem004</dc:identifier>
<dc:title><![CDATA[Evaluation of Antioxidant and Wound Healing Effects of Alcoholic and Aqueous Extract of Ocimum sanctum Linn in Rats]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>101</prism:endingPage>
<prism:publicationDate>2008-03-01</prism:publicationDate>
<prism:startingPage>95</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/1/103?rss=1">
<title><![CDATA[Single-blind and Double-blind Randomized Controlled Trials of Palmtherapy(R), an Alternative Medical Approach, for Anxiety before Cardiac Catheterization]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/1/103?rss=1</link>
<description><![CDATA[
<p>Alternative medicine is widely used, but lacks consensus regarding its amenability to scientific investigation. Anxiety increases morbidity and mortality in ischemic heart disease. We performed two studies of Palmtherapy&reg;, an alternative treatment, for anxiety before cardiac catheterization. In the first study, patients were randomized to receive pressure at particular points on the palm, or at incorrect locations, for about 50 min, while the therapist conversed with them. In the second study, the conversation was conducted by a second, &lsquo;blind&rsquo; investigator. In both studies, patients and nurses, all blind to treatment assignment, completed visual analog scale and National Institute of Mental Health measures of anxiety, respectively. Twenty-three subjects completed study 1, and 17 completed study 2. In study 1, palm therapy was superior to sham therapy for both outcome measures. In study 2, palm therapy was superior for self-reported anxiety, but not for nurses&rsquo; assessments of anxiety. Future studies should attempt to separate possible mechanistic effects of Palmtherapy&reg; from therapist-related variables. Whether alternative medicine deserves to be studied at all remains controversial. Palmtherapy&reg; may offer anxiolytic benefit without the harm attributable to drugs.</p>
]]></description>
<dc:creator><![CDATA[Blaer, Y., Jafari, J., Podberezsky, A., David, T., Reizin, L., Benjamin, J.]]></dc:creator>
<dc:date>2008-02-21</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nel111</dc:identifier>
<dc:title><![CDATA[Single-blind and Double-blind Randomized Controlled Trials of Palmtherapy(R), an Alternative Medical Approach, for Anxiety before Cardiac Catheterization]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>105</prism:endingPage>
<prism:publicationDate>2008-03-01</prism:publicationDate>
<prism:startingPage>103</prism:startingPage>
<prism:section>Original Articles - Clinical Analyses</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/1/107?rss=1">
<title><![CDATA[Exploring of Antimicrobial Activity of Triphala Mashi--an Ayurvedic Formulation]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/1/107?rss=1</link>
<description><![CDATA[
<p>Triphala <I>Mashi</I> is an ayurvedic formulation that was prepared in our lab. Aqueous and alcoholic extracts of both Triphala and Triphala <I>Mashi</I> were used, to evaluate antimicrobial activity. Comparative phytochemical profile of Triphala and Triphala <I>Mashi</I> was done by preliminary phytochemical screening, total phenolic content and thin layer chromatography (TLC). Antimicrobial activity includes isolation of pathogens from clinical samples, its characterization, testing its multiple drug resistance against standard antibiotics and antimicrobial activity of aqueous and alcoholic extracts of both Triphala and Triphala <I>Mashi</I> against these organisms by using agar gel diffusion method. Triphala <I>Mashi</I> containing phenolic compounds, tannins exhibited comparable antimicrobial activity in relation to Triphala against all the microorganisms tested. It inhibits the dose-dependent growth of Gram-positive and Gram-negative bacteria. In conclusion, it appears that Triphala <I>Mashi</I> has non-specific antimicrobial activity.</p>
]]></description>
<dc:creator><![CDATA[Biradar, Y. S., Jagatap, S., Khandelwal, K. R., Singhania, S. S.]]></dc:creator>
<dc:date>2008-02-21</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem002</dc:identifier>
<dc:title><![CDATA[Exploring of Antimicrobial Activity of Triphala Mashi--an Ayurvedic Formulation]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>113</prism:endingPage>
<prism:publicationDate>2008-03-01</prism:publicationDate>
<prism:startingPage>107</prism:startingPage>
<prism:section>Original Articles - Clinical Analyses</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/1/115?rss=1">
<title><![CDATA[Scientific Publications: Methods and Skills Workshop, C-DAC Conference Hall, University of Pune, Pune, India, November 9, 2006]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/1/115?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Joglekar, V. P.]]></dc:creator>
<dc:date>2008-02-21</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem038</dc:identifier>
<dc:title><![CDATA[Scientific Publications: Methods and Skills Workshop, C-DAC Conference Hall, University of Pune, Pune, India, November 9, 2006]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>115</prism:endingPage>
<prism:publicationDate>2008-03-01</prism:publicationDate>
<prism:startingPage>115</prism:startingPage>
<prism:section>Meeting Reports</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/1/117?rss=1">
<title><![CDATA[Symposium on Pharmacovigilance of Herbal Medicines, London, March 28, 2006]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/1/117?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Firenzuoli, F., Gori, L., Menniti-Ippolito, F.]]></dc:creator>
<dc:date>2008-02-21</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem022</dc:identifier>
<dc:title><![CDATA[Symposium on Pharmacovigilance of Herbal Medicines, London, March 28, 2006]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>118</prism:endingPage>
<prism:publicationDate>2008-03-01</prism:publicationDate>
<prism:startingPage>117</prism:startingPage>
<prism:section>Meeting Reports</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/1/119?rss=1">
<title><![CDATA[Corrigendum]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/1/119?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>2008-02-21</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen008</dc:identifier>
<dc:title><![CDATA[Corrigendum]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>119</prism:endingPage>
<prism:publicationDate>2008-03-01</prism:publicationDate>
<prism:startingPage>119</prism:startingPage>
<prism:section>Corrigendum</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/4/4/399?rss=1">
<title><![CDATA[eCAM: Moving Forward]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/4/4/399?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Cooper, E. L.]]></dc:creator>
<dc:date>2008-01-07</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem173</dc:identifier>
<dc:title><![CDATA[eCAM: Moving Forward]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>4</prism:volume>
<prism:endingPage>400</prism:endingPage>
<prism:publicationDate>2007-12-01</prism:publicationDate>
<prism:startingPage>399</prism:startingPage>
<prism:section>Editorial</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/4/4/401?rss=1">
<title><![CDATA[Antidiabetes and Anti-obesity Activity of Lagerstroemia speciosa]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/4/4/401?rss=1</link>
<description><![CDATA[
<p>The leaves of <I>Lagerstroemia speciosa</I> (Lythraceae), a Southeast Asian tree more commonly known as banaba, have been traditionally consumed in various forms by Philippinos for treatment of diabetes and kidney related diseases. In the 1990s, the popularity of this herbal medicine began to attract the attention of scientists worldwide. Since then, researchers have conducted numerous <I>in vitro</I> and <I>in vivo</I> studies that consistently confirmed the antidiabetic activity of banaba. Scientists have identified different components of banaba to be responsible for its activity. Using tumor cells as a cell model, corosolic acid was isolated from the methanol extract of banaba and shown to be an active compound. More recently, a different cell model and the focus on the water soluble fraction of the extract led to the discovery of other compounds. The ellagitannin Lagerstroemin was identified as an effective component of the banaba extract responsible for the activity. In a different approach, using 3T3-L1 adipocytes as a cell model and a glucose uptake assay as the functional screening method, Chen <I>et al</I>. showed that the banaba water extract exhibited an insulin-like glucose transport inducing activity. Coupling HPLC fractionation with a glucose uptake assay, gallotannins were identified in the banaba extract as components responsible for the activity, not corosolic acid. Penta-<I>O</I>-galloyl-glucopyranose (PGG) was identified as the most potent gallotannin. A comparison of published data with results obtained for PGG indicates that PGG has a significantly higher glucose transport stimulatory activity than Lagerstroemin. Chen <I>et al</I>. have also shown that PGG exhibits anti-adipogenic properties in addition to stimulating the glucose uptake in adipocytes. The combination of glucose uptake and anti-adipogenesis activity is not found in the current insulin mimetic drugs and may indicate a great therapeutic potential of PGG.</p>
]]></description>
<dc:creator><![CDATA[Klein, G., Kim, J., Himmeldirk, K., Cao, Y., Chen, X.]]></dc:creator>
<dc:date>2008-01-07</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem013</dc:identifier>
<dc:title><![CDATA[Antidiabetes and Anti-obesity Activity of Lagerstroemia speciosa]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>4</prism:volume>
<prism:endingPage>407</prism:endingPage>
<prism:publicationDate>2007-12-01</prism:publicationDate>
<prism:startingPage>401</prism:startingPage>
<prism:section>Reviews</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/4/4/409?rss=1">
<title><![CDATA[Complementary and Alternative Approaches to Pain Relief During Labor]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/4/4/409?rss=1</link>
<description><![CDATA[
<p>This review evaluated the effect of complementary and alternative medicine on pain during labor with conventional scientific methods using electronic data bases through 2006 were used. Only randomized controlled trials with outcome measures for labor pain were kept for the conclusions. Many studies did not meet the scientific inclusion criteria. According to the randomized control trials, we conclude that for the decrease of labor pain and/or reduction of the need for conventional analgesic methods: (i) There is an efficacy found for acupressure and sterile water blocks. (ii) Most results favored some efficacy for acupuncture and hydrotherapy. (iii) Studies for other complementary or alternative therapies for labor pain control have not shown their effectiveness.</p>
]]></description>
<dc:creator><![CDATA[Tournaire, M., Theau-Yonneau, A.]]></dc:creator>
<dc:date>2008-01-07</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem012</dc:identifier>
<dc:title><![CDATA[Complementary and Alternative Approaches to Pain Relief During Labor]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>4</prism:volume>
<prism:endingPage>417</prism:endingPage>
<prism:publicationDate>2007-12-01</prism:publicationDate>
<prism:startingPage>409</prism:startingPage>
<prism:section>Reviews</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/4/4/419?rss=1">
<title><![CDATA[Immunomodulatory Activity of Chlorophytum borivilianum Sant. F]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/4/4/419?rss=1</link>
<description><![CDATA[
<p><I>Chlorophytum borivilianum</I> Santapau &amp; Fernandes (Liliaceae) is a very popular herb in traditional Indian medicine and constitute a group of herbs used as &lsquo;Rasayan&rsquo; or adaptogen. Ethanolic extract of the roots and its sapogenin were evaluated for their immunomodulatory activity. Effect of azathioprine-induced myelosuppresion and administration of extracts on hematological and serological parameters was determined. Administration of extracts greatly improved survival against <I>Candida albicans</I> infection. An increase in delayed-type hypersensitivity response (DTH), % neutrophil adhesion and <I>in vivo</I> phagocytosis by carbon clearance method was observed after treatment with extracts. Immunostimulant activity of ethanolic extract was more pronounced as compared to sapogenins. The results, thus justifies the traditional use of <I>C. borivilianum</I> as a rasayana drug.</p>
]]></description>
<dc:creator><![CDATA[Thakur, M., Bhargava, S., Dixit, V. K.]]></dc:creator>
<dc:date>2008-01-07</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nel094</dc:identifier>
<dc:title><![CDATA[Immunomodulatory Activity of Chlorophytum borivilianum Sant. F]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>4</prism:volume>
<prism:endingPage>423</prism:endingPage>
<prism:publicationDate>2007-12-01</prism:publicationDate>
<prism:startingPage>419</prism:startingPage>
<prism:section>Original Articles - Basic Sciences</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/4/4/425?rss=1">
<title><![CDATA[Elucidation of Danzhixiaoyao Wan and Its Constituent Herbs on Antioxidant Activity and Inhibition of Nitric Oxide Production]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/4/4/425?rss=1</link>
<description><![CDATA[
<p>Danzhixiaoyao Wan (DW) is a common 10 herbs formulation in China for regulating several clinical conditions affecting women. This research tried to explain one of DW's functions, purging heat, using <I>in vitro</I> pharmacological analyses. The whole formulation and each single herb of DW were compared based on antioxidant activity with the oxygen radical absorbance capacity (ORAC) assay, and for their inhibitory effect (IE) on nitric oxide (NO) production by lipopolysaccharide (LPS)-activated RAW 264.7 macrophages with the Griess assay. The results showed that DW as a whole formulation had both antioxidant activity and an IE on NO production, while the individual herb component of DW varied in their ORAC values and inhibition of NO production. The ORAC value of the whole DW was 450 &micro;mol TE g<sup>&ndash;1</sup>. The order of antioxidant (ORAC) activity of the single herbs was: <I>Mentha haplocalyx</I> (1352 &micro;mol TE g<sup>&ndash;1</sup>) &gt; <I>Glycyrrhiza uralensis</I> (1184 &micro;mol TE g<sup>&ndash;1</sup>) &gt; <I>Gardenia jasminoides</I> (1129 &micro;mol TE g<sup>&ndash;1</sup>) &gt; <I>Paeonia suffruticosa</I> (465 &micro;mol TE g<sup>&ndash;1</sup>), with the contributions being additive rather than synergistic. The production of nitrite by stimulated RAW 264.7 murine macrophages (unstimulated: 0.5 &plusmn; 0.1 &micro;M versus LPS: 38.9 &plusmn; 2.3 &micro;M) was significantly inhibited (<I>P</I> &lt; 0.05) by <I>M. haplocalyx</I>, <I>G. jasminoides</I>, <I>Bupleurum chinense</I> and <I>Paeonia lactiflora</I>. DW as a whole had an IE on NO production, but this was not significant. The single herb <I>M. haplocalyx</I> had the highest ORAC value and the highest IE on NO production, followed by <I>G. jasminoides</I>. Both of these herbs have the &lsquo;purging heat&rsquo; property in the theory of traditional Chinese medicine and this property of the samples may be correlated with the antioxidant activity and IE on NO production.</p>
]]></description>
<dc:creator><![CDATA[Liao, H., Banbury, L. K., Leach, D. N.]]></dc:creator>
<dc:date>2008-01-07</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nel091</dc:identifier>
<dc:title><![CDATA[Elucidation of Danzhixiaoyao Wan and Its Constituent Herbs on Antioxidant Activity and Inhibition of Nitric Oxide Production]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>4</prism:volume>
<prism:endingPage>430</prism:endingPage>
<prism:publicationDate>2007-12-01</prism:publicationDate>
<prism:startingPage>425</prism:startingPage>
<prism:section>Original Articles - Basic Sciences</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/4/4/431?rss=1">
<title><![CDATA[Acupuncture for Chronic Pain in Japan: A Review]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/4/4/431?rss=1</link>
<description><![CDATA[
<p>Many Japanese reports of acupuncture and moxibustion for chronic pain are not listed in medical databases such as Medline. Therefore, they are not easily accessible to researchers outside of Japan. To complement existing reviews of acupuncture and moxibustion for chronic pain and to provide more detailed discussion and analysis, we did a literature search using &lsquo;Igaku Chuo Zasshi Wed&rsquo; (Japana Centra Revuo Medicina) and &lsquo;Citation Information by National Institute of Information&rsquo; covering the period 1978&ndash;2006. Original articles and case reports of acupuncture and moxibustion treatment of chronic pain were included. Animal studies, surveys, and news articles were excluded. Two independent reviewers extracted data from located articles in a pre-defined structured way, and assessed the likelihood of causality in each case. We located 57 papers written in Japanese (20 full papers, 37 case reports). Conditions examined were headache (12 trials), chronic low back pain (9 trials), rheumatoid arthritis (8 trials), temporomandibular dysfunction (8 trials), katakori (8 trials) and others (12 trials). While 23 were described as clinical control trials (CCTs), 11 employed a quasi-random method. Applying the 5-point Jadad quality assessment scoring system, the mean score was 1.5 &plusmn; 1.3 (SD). Eleven (52%) of the CCTs were conducted to determine a more effective procedure for acupuncture; these compared a certain type of acupuncture with another type of acupuncture or specific additional points. In particular, the trigger point acupuncture was widely used to treat chronic low back pain in Japan. Many reports of chronic pain treatment by acupuncture and moxibustion are listed in Japanese databases. From the data, we conclude that there is limited evidence that acupuncture is more effective than no treatment, and inconclusive evidence that trigger point acupuncture is more effective than placebo, sham acupuncture or standard care.</p>
]]></description>
<dc:creator><![CDATA[Itoh, K., Kitakoji, H.]]></dc:creator>
<dc:date>2008-01-07</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nel092</dc:identifier>
<dc:title><![CDATA[Acupuncture for Chronic Pain in Japan: A Review]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>4</prism:volume>
<prism:endingPage>438</prism:endingPage>
<prism:publicationDate>2007-12-01</prism:publicationDate>
<prism:startingPage>431</prism:startingPage>
<prism:section>Original Articles - Basic Sciences</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/4/4/439?rss=1">
<title><![CDATA[Perillyl Alcohol Protects Against Fe-NTA-Induced Nephrotoxicity and Early Tumor Promotional Events in Rat Experimental Model]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/4/4/439?rss=1</link>
<description><![CDATA[
<p>Plants have been widely used as protective agents against a wide variety of processes and compounds that damage tissues via free radical mechanisms. Perillyl alcohol (PA) is a naturally occurring monoterpene found in the essential oils of numerous species of plants including mints, cherries and celery seeds. This monocyclic monoterpene has shown antioxidant and therapeutic activity in various studies against various xenobiotics. In this study, we have analyzed the effects of PA against single intraperitoneal dose of ferric nitrilotriacetate (Fe-NTA) (9 mg iron per kg body weight)-induced nephrotoxicity and early tumor promotional events. The pretreatment of Fe-NTA-treated rats with 0.5% per kg body weight dose and 1% per kg body weight dose of PA for seven consecutive days significantly reversed the Fe-NTA-induced malondialdehyde formation, xanthine oxidase activity (<I>P</I> &lt; 0.001), ornithine decarboxylase activity (<I>P</I> &lt; 0.001) and <sup>3</sup>[H]thymidine incorporation in renal DNA (<I>P</I> &lt; 0.001) with simultaneous significant depletion in serum toxicity markers blood urea nitrogen and creatinine (<I>P</I> &lt; 0.001). Significant restoration at both the doses was recorded in depleted renal glutathione content, and its dependent enzymes with prophylactic treatment of PA. Present results suggest that PA potentially attenuates against Fe-NTA-induced oxidative damage and tumor promotional events that preclude its development as a future drug to avert the free radical-induced toxicity.</p>
]]></description>
<dc:creator><![CDATA[Jahangir, T., Sultana, S.]]></dc:creator>
<dc:date>2008-01-07</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nel104</dc:identifier>
<dc:title><![CDATA[Perillyl Alcohol Protects Against Fe-NTA-Induced Nephrotoxicity and Early Tumor Promotional Events in Rat Experimental Model]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>4</prism:volume>
<prism:endingPage>445</prism:endingPage>
<prism:publicationDate>2007-12-01</prism:publicationDate>
<prism:startingPage>439</prism:startingPage>
<prism:section>Original Articles - Basic Sciences</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/4/4/447?rss=1">
<title><![CDATA[Acupuncture Regulates Leukocyte Subpopulations in Human Peripheral Blood]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/4/4/447?rss=1</link>
<description><![CDATA[
<p>Acupuncture has recently been attracting more and more people throughout the world as an alternative treatment, however little is known about its physiological activities (i.e. immune system). We examined acupuncture both quantitatively and qualitatively by measuring CD-positive cell counts and cytokine expression levels in the blood, to determine the activity of T cells, B cells, macrophages and natural killer (NK) cells. Fifteen milliliters of peripheral blood obtained from 17 healthy volunteers aged 21&ndash;51 years, were analyzed using flow cytometry before and after acupuncture treatment. There was a statistically significant increase in the number of CD2<sup>+</sup>, CD4<sup>+</sup>, CD8<sup>+</sup>, CD11b<sup>+</sup>, CD16<sup>+</sup>, CD19<sup>+</sup>, CD56<sup>+</sup> cells as well as IL-4, IL-1&beta; and IFN- levels in the cells after acupuncture stimulation of meridian points. These observations indicate that acupuncture may regulate the immune system and promote the activities of humoral and cellular immunity as well as NK cell activity. In this article, we discussed how acupuncture regulated leukocyte numbers and functions since they are considered to be potential indicators for evaluating complementary and alternative medicine.</p>
]]></description>
<dc:creator><![CDATA[Yamaguchi, N., Takahashi, T., Sakuma, M., Sugita, T., Uchikawa, K., Sakaihara, S., Kanda, T., Arai, M., Kawakita, K.]]></dc:creator>
<dc:date>2008-01-07</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nel107</dc:identifier>
<dc:title><![CDATA[Acupuncture Regulates Leukocyte Subpopulations in Human Peripheral Blood]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>4</prism:volume>
<prism:endingPage>453</prism:endingPage>
<prism:publicationDate>2007-12-01</prism:publicationDate>
<prism:startingPage>447</prism:startingPage>
<prism:section>Original Articles - Clinical Analyses</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/4/4/455?rss=1">
<title><![CDATA[Juice Powder Concentrate and Systemic Blood Pressure, Progression of Coronary Artery Calcium and Antioxidant Status in Hypertensive Subjects: A Pilot Study]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/4/4/455?rss=1</link>
<description><![CDATA[
<p>Because micronutrients from plants may have beneficial cardiovascular effects, the hypothesis that an encapsulated juice powder concentrate might affect several measures of vascular health was tested in free living adults at low cardiovascular risk. Blood pressure, vascular compliance, lipid and antioxidant markers, and serial electron beam tomography (to calculate a coronary artery calcium score as a measure of atherosclerosis burden), were monitored in 51 pre-hypertensive and hypertensive subjects over 2 years. By the end of follow-up, systolic and diastolic blood pressure decreased significantly (&ndash;2.4 &plusmn; 1.0 mmHg, <I>P</I> &lt; 0.05 and &ndash;2.2 &plusmn; 0.6 mmHg, <I>P</I> &lt; 0.001), and large artery compliance improved significantly (1.9 &plusmn; 0.6 ml mmHg<sup>&ndash;1</sup> <FONT FACE="arial,helvetica">x</FONT> 100, <I>P</I> &lt; 0.01). The progression of coronary artery calcium score was smaller than expected compared with a historical database (<I>P</I> &lt; 0.001). Laboratory testing showed a significant decrease in homocysteine (<I>P</I> = 0.05), HDL cholesterol (<I>P</I> = 0.025) and Apo A (<I>P</I> = 0.004), as well as a significant increase in &beta;-carotene, folate, Co-Q10 and -tocopherol (all <I>P</I> &lt; 0.001). The phytonutrient concentrate we utilized induced several favorable modifications of markers of vascular health in the subjects. This study supports the notion that plant nutrients are important components of a heart healthy diet.</p>
]]></description>
<dc:creator><![CDATA[Houston, M. C., Cooil, B., Olafsson, B. J., Raggi, P.]]></dc:creator>
<dc:date>2008-01-07</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nel108</dc:identifier>
<dc:title><![CDATA[Juice Powder Concentrate and Systemic Blood Pressure, Progression of Coronary Artery Calcium and Antioxidant Status in Hypertensive Subjects: A Pilot Study]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>4</prism:volume>
<prism:endingPage>462</prism:endingPage>
<prism:publicationDate>2007-12-01</prism:publicationDate>
<prism:startingPage>455</prism:startingPage>
<prism:section>Original Articles - Clinical Analyses</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/4/4/463?rss=1">
<title><![CDATA[Two Kampo Medicines, Jidabokuippo and Hachimijiogan Alleviate Sprains, Bruises and Arthritis]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/4/4/463?rss=1</link>
<description><![CDATA[
<p>In traditional Chinese medicine theory (TCM), the affected parts of sprains, bruises and arthritis are considered to be under certain conditions of TCM concept. We administered two Kampo medicines with synergistic effects to promote quick recovery from these conditions. Jidabokuippo (Zhidapuyifang in Chinese), which means &lsquo;decoction for contusions&rsquo; is expected to remove these conditions. Hachimijiogan (Baweidihuangwan in Chinese), which translates as &lsquo;eight-ingredient pill with Rehmannia&rsquo; is expected to restore presumed minute bone injury and regulates bone metabolism by changing such conditions based on TCM theory. We administered the two prescriptions to 10 patients (age range: 40&ndash;85 years; 1 male, 9 females) suffering from bruises, sprains, arthritis and spinal compression fracture without changing their routine intake of other drugs. Patients reported on changes in the pain of affected body parts by using the visual analog scale (VAS) before and after administration of Kampo medicine. In almost all cases, recovery began promptly after administration and the pain disappeared within ~2 weeks. Large doses for a short time brought about much quicker recovery than small doses. Administration of a combination of two Kampo medicines, Jidabokuippo and Hachimijiogan, quickly resolved the pain of bruises, sprains, arthritis and one spinal compression fracture.</p>
]]></description>
<dc:creator><![CDATA[Hijikata, Y., Miyamae, Y., Takatsu, H., Sentoh, S.]]></dc:creator>
<dc:date>2008-01-07</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nel105</dc:identifier>
<dc:title><![CDATA[Two Kampo Medicines, Jidabokuippo and Hachimijiogan Alleviate Sprains, Bruises and Arthritis]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>4</prism:volume>
<prism:endingPage>467</prism:endingPage>
<prism:publicationDate>2007-12-01</prism:publicationDate>
<prism:startingPage>463</prism:startingPage>
<prism:section>Original Articles - Clinical Analyses</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/4/4/469?rss=1">
<title><![CDATA[The Influence of Yoga-Based Programs on Risk Profiles in Adults with Type 2 Diabetes Mellitus: A Systematic Review]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/4/4/469?rss=1</link>
<description><![CDATA[
<p>There is growing evidence that yoga may offer a safe and cost-effective intervention for Type 2 Diabetes mellitus (DM 2). However, systematic reviews are lacking. This article critically reviews the published literature regarding the effects of yoga-based programs on physiologic and anthropometric risk profiles and related clinical outcomes in adults with DM 2. We performed a comprehensive literature search using four computerized English and Indian scientific databases. The search was restricted to original studies (1970&ndash;2006) that evaluated the metabolic and clinical effects of yoga in adults with DM 2. Studies targeting clinical populations with cardiovascular disorders that included adults with comorbid DM were also evaluated. Data were extracted regarding study design, setting, target population, intervention, comparison group or condition, outcome assessment, data analysis and presentation, follow-up, and key results, and the quality of each study was evaluated according to specific predetermined criteria. We identified 25 eligible studies, including 15 uncontrolled trials, 6 non-randomized controlled trials and 4 randomized controlled trials (RCTs). Overall, these studies suggest beneficial changes in several risk indices, including glucose tolerance and insulin sensitivity, lipid profiles, anthropometric characteristics, blood pressure, oxidative stress, coagulation profiles, sympathetic activation and pulmonary function, as well as improvement in specific clinical outcomes. Yoga may improve risk profiles in adults with DM 2, and may have promise for the prevention and management of cardiovascular complications in this population. However, the limitations characterizing most studies preclude drawing firm conclusions. Additional high-quality RCTs are needed to confirm and further elucidate the effects of standardized yoga programs in populations with DM 2.</p>
]]></description>
<dc:creator><![CDATA[Innes, K. E., Vincent, H. K.]]></dc:creator>
<dc:date>2008-01-07</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nel103</dc:identifier>
<dc:title><![CDATA[The Influence of Yoga-Based Programs on Risk Profiles in Adults with Type 2 Diabetes Mellitus: A Systematic Review]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>4</prism:volume>
<prism:endingPage>486</prism:endingPage>
<prism:publicationDate>2007-12-01</prism:publicationDate>
<prism:startingPage>469</prism:startingPage>
<prism:section>Reviews</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/4/4/487?rss=1">
<title><![CDATA[A Review of Yoga Programs for Four Leading Risk Factors of Chronic Diseases]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/4/4/487?rss=1</link>
<description><![CDATA[
<p>Yoga, a form of physical activity, is rapidly gaining in popularity and has many health benefits. Yet healthcare providers have been slow to recognize yoga for its ability to improve health conditions, and few interventions have been developed that take full advantage of its benefits. The purpose of this article is to review published studies using yoga programs and to determine the effect of yoga interventions on common risk factors of chronic diseases (overweight, hypertension, high glucose level and high cholesterol). A systematic search yielded 32 articles published between 1980 and April 2007. The studies found that yoga interventions are generally effective in reducing body weight, blood pressure, glucose level and high cholesterol, but only a few studies examined long-term adherence. Additionally, not enough studies included diverse populations at high risk for diabetes and its related common health problems.</p>
]]></description>
<dc:creator><![CDATA[Yang, K.]]></dc:creator>
<dc:date>2008-01-07</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem154</dc:identifier>
<dc:title><![CDATA[A Review of Yoga Programs for Four Leading Risk Factors of Chronic Diseases]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>4</prism:volume>
<prism:endingPage>491</prism:endingPage>
<prism:publicationDate>2007-12-01</prism:publicationDate>
<prism:startingPage>487</prism:startingPage>
<prism:section>Reviews</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/4/4/493?rss=1">
<title><![CDATA[Yoga as a Complementary Treatment of Depression: Effects of Traits and Moods on Treatment Outcome]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/4/4/493?rss=1</link>
<description><![CDATA[
<p>Preliminary findings support the potential of yoga as a complementary treatment of depressed patients who are taking anti-depressant medications but who are only in partial remission. The purpose of this article is to present further data on the intervention, focusing on individual differences in psychological, emotional and biological processes affecting treatment outcome. Twenty-seven women and 10 men were enrolled in the study, of whom 17 completed the intervention and pre- and post-intervention assessment data. The intervention consisted of 20 classes led by senior Iyengar yoga teachers, in three courses of 20 yoga classes each. All participants were diagnosed with unipolar major depression in partial remission. Psychological and biological characteristics were assessed pre- and post-intervention, and participants rated their mood states before and after each class. Significant reductions were shown for depression, anger, anxiety, neurotic symptoms and low frequency heart rate variability in the 17 completers. Eleven out of these completers achieved remission levels post-intervention. Participants who remitted differed from the non-remitters at intake on several traits and on physiological measures indicative of a greater capacity for emotional regulation. Moods improved from before to after the yoga classes. Yoga appears to be a promising intervention for depression; it is cost-effective and easy to implement. It produces many beneficial emotional, psychological and biological effects, as supported by observations in this study. The physiological methods are especially useful as they provide objective markers of the processes and effectiveness of treatment. These observations may help guide further clinical application of yoga in depression and other mental health disorders, and future research on the processes and mechanisms.</p>
]]></description>
<dc:creator><![CDATA[Shapiro, D., Cook, I. A., Davydov, D. M., Ottaviani, C., Leuchter, A. F., Abrams, M.]]></dc:creator>
<dc:date>2008-01-07</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nel114</dc:identifier>
<dc:title><![CDATA[Yoga as a Complementary Treatment of Depression: Effects of Traits and Moods on Treatment Outcome]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>4</prism:volume>
<prism:endingPage>502</prism:endingPage>
<prism:publicationDate>2007-12-01</prism:publicationDate>
<prism:startingPage>493</prism:startingPage>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/4/4/503?rss=1">
<title><![CDATA[Yoga Reduces Symptoms of Distress in Tsunami Survivors in the Andaman Islands]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/4/4/503?rss=1</link>
<description><![CDATA[
<p>A month after the December 2004 tsunami the effect of a 1 week yoga program was evaluated on self rated fear, anxiety, sadness and disturbed sleep in 47 survivors in the Andaman Islands. Polygraph recordings of the heart rate, breath rate and skin resistance were also made. Among the 47 people, 31 were settlers from the mainland (i.e. India, ML group) and 16 were endogenous people (EP group). There was a significant decrease in self rated fear, anxiety, sadness and disturbed sleep in both groups, and in the heart and breath rate in the ML group, and in the breath rate alone in the EP group, following yoga (<I>P</I> &lt; 0.05, <I>t</I>-test). This suggests that yoga practice may be useful in the management of stress following a natural disaster in people with widely differing social, cultural and spiritual beliefs.</p>
]]></description>
<dc:creator><![CDATA[Telles, S., Naveen, K. V., Dash, M.]]></dc:creator>
<dc:date>2008-01-07</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem069</dc:identifier>
<dc:title><![CDATA[Yoga Reduces Symptoms of Distress in Tsunami Survivors in the Andaman Islands]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>4</prism:volume>
<prism:endingPage>509</prism:endingPage>
<prism:publicationDate>2007-12-01</prism:publicationDate>
<prism:startingPage>503</prism:startingPage>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/4/4/511?rss=1">
<title><![CDATA[Iyengar Yoga Increases Cardiac Parasympathetic Nervous Modulation Among Healthy Yoga Practitioners]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/4/4/511?rss=1</link>
<description><![CDATA[
<p>Relaxation techniques are established in managing of cardiac patients during rehabilitation aiming to reduce future adverse cardiac events. It has been hypothesized that relaxation-training programs may significantly improve cardiac autonomic nervous tone. However, this has not been proven for all available relaxation techniques. We tested this assumption by investigating cardiac vagal modulation during yoga.We examined 11 healthy yoga practitioners (7 women and 4 men, mean age: 43 &plusmn; 11; range: 26&ndash;58 years). Each individual was subjected to training units of 90 min once a week over five successive weeks. During two sessions, they practiced a yoga program developed for cardiac patients by B.K.S. Iyengar. On three sessions, they practiced a placebo program of relaxation. On each training day they underwent ambulatory 24 h Holter monitoring. The group of yoga practitioners was compared to a matched group of healthy individuals not practicing any relaxation techniques. Parameters of heart rate variability (HRV) were determined hourly by a blinded observer. Mean RR interval (interval between two R-waves of the ECG) was significantly higher during the time of yoga intervention compared to placebo and to control (<I>P</I> &lt; 0.001 for both). The increase in HRV parameters was significantly higher during yoga exercise than during placebo and control especially for the parameters associated with vagal tone, i.e. mean standard deviation of NN (Normal Beat to Normal Beat of the ECG) intervals for all 5-min intervals (SDNNi, <I>P</I> &lt; 0.001 for both) and root mean square successive difference (rMSSD, <I>P</I> &lt; 0.01 for both). In conclusion, relaxation by yoga training is associated with a significant increase of cardiac vagal modulation. Since this method is easy to apply with no side effects, it could be a suitable intervention in cardiac rehabilitation programs.</p>
]]></description>
<dc:creator><![CDATA[Khattab, K., Khattab, A. A., Ortak, J., Richardt, G., Bonnemeier, H.]]></dc:creator>
<dc:date>2008-01-07</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem087</dc:identifier>
<dc:title><![CDATA[Iyengar Yoga Increases Cardiac Parasympathetic Nervous Modulation Among Healthy Yoga Practitioners]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>4</prism:volume>
<prism:endingPage>517</prism:endingPage>
<prism:publicationDate>2007-12-01</prism:publicationDate>
<prism:startingPage>511</prism:startingPage>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/4/4/519?rss=1">
<title><![CDATA[A Phase I Feasibility Study of Yoga on the Physical Health and Coping of Informal Caregivers]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/4/4/519?rss=1</link>
<description><![CDATA[
<p>Family and friends who provide unpaid care to an individual with a disease or disability (known as informal caregivers) experience numerous threats to their physical health as a result of providing care. In spite of evidence that participation in physical and leisure activities can be health promoting, informal caregivers have reported diminished or completely absent leisure participation. Hatha yoga has documented therapeutic benefits, including reduced anxiety, as well as improved muscle strength and endurance and flexibility. The purpose of this study was to determine the feasibility of conducting an 8-week yoga program with informal caregivers, and to gather pilot data on the effects of yoga on the physical fitness and coping of informal caregivers. Caregivers were randomized into a yoga intervention (<I>n</I> = 8) or control group (<I>n</I> = 9). The yoga sessions were 2.5 hours/week for 8 weeks and consisted of a variety of pranayama (breathing) and asana (postures) activities and were led by a certified yoga instructor. Four caregivers (two in each group) dropped out of the study. After the conclusion of the 8-week yoga program, lower body strength increased significantly for those in the yoga group and other notable trends occurred in terms of coping, upper body strength and aerobic endurance. Caregivers in the control group experienced an unexpected increase in lower body flexibility. These findings indicate that caregivers in a yoga program may receive some benefits. Future studies are encouraged to test the efficacy of yoga as an intervention for caregivers.</p>
]]></description>
<dc:creator><![CDATA[Van Puymbroeck, M., Payne, L. L., Hsieh, P.-C.]]></dc:creator>
<dc:date>2008-01-07</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem075</dc:identifier>
<dc:title><![CDATA[A Phase I Feasibility Study of Yoga on the Physical Health and Coping of Informal Caregivers]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>4</prism:volume>
<prism:endingPage>529</prism:endingPage>
<prism:publicationDate>2007-12-01</prism:publicationDate>
<prism:startingPage>519</prism:startingPage>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/4/suppl_1/1?rss=1">
<title><![CDATA[European Traditional Medicine   International Congress Mayor's Introduction]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/4/suppl_1/1?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Parrini, D.]]></dc:creator>
<dc:date>2007-10-04</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem133</dc:identifier>
<dc:title><![CDATA[European Traditional Medicine   International Congress Mayor's Introduction]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>Supplement 1</prism:number>
<prism:volume>4</prism:volume>
<prism:endingPage>1</prism:endingPage>
<prism:publicationDate>2007-09-01</prism:publicationDate>
<prism:startingPage>1</prism:startingPage>
<prism:section>European Traditional Medicine - International Congress Mayor's Introduction</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/4/suppl_1/3?rss=1">
<title><![CDATA[European Traditional Medicine   International Congress   Introductory Statement]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/4/suppl_1/3?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Firenzuoli, F., Gori, L.]]></dc:creator>
<dc:date>2007-10-04</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem134</dc:identifier>
<dc:title><![CDATA[European Traditional Medicine   International Congress   Introductory Statement]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>Supplement 1</prism:number>
<prism:volume>4</prism:volume>
<prism:endingPage>4</prism:endingPage>
<prism:publicationDate>2007-09-01</prism:publicationDate>
<prism:startingPage>3</prism:startingPage>
<prism:section>European Traditional Medicine - International Congress - Introductory Statement</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/4/suppl_1/5?rss=1">
<title><![CDATA[The Immune System and Complementary and Alternative Medicine]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/4/suppl_1/5?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Cooper, E. L.]]></dc:creator>
<dc:date>2007-10-04</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem093</dc:identifier>
<dc:title><![CDATA[The Immune System and Complementary and Alternative Medicine]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>Supplement 1</prism:number>
<prism:volume>4</prism:volume>
<prism:endingPage>8</prism:endingPage>
<prism:publicationDate>2007-09-01</prism:publicationDate>
<prism:startingPage>5</prism:startingPage>
<prism:section>Editorial</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/4/suppl_1/9?rss=1">
<title><![CDATA[The Diseases of the Medici Family and the Use of Phytotherapy]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/4/suppl_1/9?rss=1</link>
<description><![CDATA[
<p>The Medici Project is a paleopathological and historico-medical research, based on the exhumation of corpses of the Medici Family buried in the Medici Chapels (Florence, San Lorenzo). The scientific research carried out on these remains permits us to reconstruct habits and causes of death of members of this famous family of Italian Renaissance. The comparison between the literary sources and the paleopathological evidence is also important to reconstruct different therapies. Physicians, who assisted the most important persons of the Medici Family, have left a rich literature about their patients: the treatments were based on the use of plants and natural substances. Analyzing these sources is of unique importance and throws light on the therapeutical choices of the time.</p>
]]></description>
<dc:creator><![CDATA[Lippi, D.]]></dc:creator>
<dc:date>2007-10-04</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem107</dc:identifier>
<dc:title><![CDATA[The Diseases of the Medici Family and the Use of Phytotherapy]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>Supplement 1</prism:number>
<prism:volume>4</prism:volume>
<prism:endingPage>11</prism:endingPage>
<prism:publicationDate>2007-09-01</prism:publicationDate>
<prism:startingPage>9</prism:startingPage>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/4/suppl_1/13?rss=1">
<title><![CDATA[Ear Acupuncture in European Traditional Medicine]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/4/suppl_1/13?rss=1</link>
<description><![CDATA[
<p>Auricular acupuncture is a diagnostic and treatment system based on normalizing the body's dysfunction through stimulation of definite points on the ear. Rudimentary forms of acupuncture which probably arose during the Stone Age have survived in many parts of the world right down to present day. It was used in the ancient Egypt, Rome, Greece and all the Mediterranean area. It is a microacupuncture technique similar to reflexology, and was first described in France in 1950 by Paul Nogier who is considered the Father of modern ear acupuncture. It was speculated that the technique works because groups of pluripotent cells contain information from the whole organism and create regional organization centers representing different parts of the body. Nevertheless stimulation of a reflex point in the ear seems relieve symptoms of distant pathologies. Modern research is confirming the efficacy of ear acupuncture for analgesia and anxiety related disease, while tobacco dependence and other substance abuse still need confirmation. Actually main methodological problems with auricular acupuncture are that exist too many maps with little agreement regarding point location in the ear, and that the correspondence or reflex systems does not correlated with modern knowledge of anatomy and physiology.</p>
]]></description>
<dc:creator><![CDATA[Gori, L., Firenzuoli, F.]]></dc:creator>
<dc:date>2007-10-04</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem106</dc:identifier>
<dc:title><![CDATA[Ear Acupuncture in European Traditional Medicine]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>Supplement 1</prism:number>
<prism:volume>4</prism:volume>
<prism:endingPage>16</prism:endingPage>
<prism:publicationDate>2007-09-01</prism:publicationDate>
<prism:startingPage>13</prism:startingPage>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/4/suppl_1/17?rss=1">
<title><![CDATA[Antimicrobial Activities of Essential Oil and Methanol Extract of Teucrium montanum]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/4/suppl_1/17?rss=1</link>
<description><![CDATA[
<p>This study was designed to examine the chemical composition of essential oil and the <I>in vitro</I> antimicrobial activities of essential oil and methanol extract of <I>Teucrium montanum</I>. The inhibitory effects of essential oil and methanol extracts of <I>T. montanum</I> were tested against 13 bacterial and three fungal species by using disc-diffusion method. GC/MS analyses revealed that essential oil contains mainly -cadinene (17.19%), &beta;-selinene (8.16%) -calacorene (4.97%), 1,6-dimethyl-4-(1-methylethyl)-naphthalene (4.91%), caryophyllene (4.35%), copaene (4.23%), torreyol (3.91%), 4-terpineol (3.90%), cadina-1,4-diene (3.39%), &beta;-sesquiphellandrene (3.34%), -cadinol (3.12%) and -curcumene (3.18%). The essential oil has antibacterial as well as antifungal effect.</p>
]]></description>
<dc:creator><![CDATA[Vukovic, N., Milosevic, T., Sukdolak, S., Solujic, S.]]></dc:creator>
<dc:date>2007-10-04</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem108</dc:identifier>
<dc:title><![CDATA[Antimicrobial Activities of Essential Oil and Methanol Extract of Teucrium montanum]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>Supplement 1</prism:number>
<prism:volume>4</prism:volume>
<prism:endingPage>20</prism:endingPage>
<prism:publicationDate>2007-09-01</prism:publicationDate>
<prism:startingPage>17</prism:startingPage>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/4/suppl_1/21?rss=1">
<title><![CDATA[RAPD Analysis for Determination of Components in Herbal Medicine]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/4/suppl_1/21?rss=1</link>
<description><![CDATA[
<p>In this study, the RAPD (Random Amplified Polymorphic DNA) technique was employed for determination of the components in an Ayurvedic herbal prescription, <I>Rasayana Churna</I>. One-hundred-and-twenty decamer oligonucleotide primers were screened in the RAPD analysis to identify three Ayurvedic medicines, dried stem of <I>Tinospora cordifolia</I>, dried fruit of <I>Emblica officinalis</I> and dried fruit of <I>Tribulus terestris</I>, the Ayurvedic prescription. Primer OPC-6 simultaneously generated three distinct amplicons, each specific to one component. The marker with 600 bp is specific to <I>Tinospora cordifolia</I>; the marker 500 bp is specific to <I>Emblica officinalis</I> and the remaining marker &gt;1000 bp was present in <I>Tribulus terestris</I>. Presence of three herbal medicines was determined when RAPD reaction with OPC-6 was performed. The technique was proved to contribute to the identification of components in Ayurvedic herbal preparation and thus helping to serve as a complementary tool for quality control.</p>
]]></description>
<dc:creator><![CDATA[Shinde, V. M., Dhalwal, K., Mahadik, K. R., Joshi, K. S., Patwardhan, B. K.]]></dc:creator>
<dc:date>2007-10-04</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem109</dc:identifier>
<dc:title><![CDATA[RAPD Analysis for Determination of Components in Herbal Medicine]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>Supplement 1</prism:number>
<prism:volume>4</prism:volume>
<prism:endingPage>23</prism:endingPage>
<prism:publicationDate>2007-09-01</prism:publicationDate>
<prism:startingPage>21</prism:startingPage>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/4/suppl_1/25?rss=1">
<title><![CDATA[Chemical Investigation of Some Capparis Species Growing in Egypt and their Antioxidant Activity]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/4/suppl_1/25?rss=1</link>
<description><![CDATA[
<p><I>Capparis cartilaginea</I> and <I>C. deserti</I> growing in Egypt were investigated for their glucosiolates and rutin content. From <I>Capparis cartilaginea</I> four isothiocynates were isolated and identified using GC and EI/MS techniques. These compounds were butyl isothiocyanate (1), 6-methylsulphonylhexyl isothiocyanate (2), 7-methylsulphonylheptyl isothiocyanate (3) and 5-benzylsulphonyl-4-pentenyl isothiocyanate (4). In addition to compounds (1) and (2), two other compounds were isolated and identified from <I>Capparis deserti</I>. These compounds are 3-methylthiopropyl isothiocyanate (5) and [11-(2-butenylthio)6-undecenyl isothiocyanate] (6). Compounds (1), (2), (5) and (6) are reported in this study for the first time from <I>Capparis deserti</I>. The main flavonoid component in the studied species was isolated and identified as rutin by comparing the data with those reported. Also, quantitative evaluation of rutin in the two species was carried out by TLC-densitometric analysis. The antioxidant activity was done using diphenylpicrylhydrazyl (DPPH) radical scavenging method. The butanol fraction from <I>C. cartilaginea</I> and <I>C. deserti</I> showed the highest antioxidant properties.</p>
]]></description>
<dc:creator><![CDATA[Hamed, A. R., Abdel-Shafeek, K. A., Abdel-Azim, N. S., Ismail, S. I., Hammouda, F. M.]]></dc:creator>
<dc:date>2007-10-04</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem110</dc:identifier>
<dc:title><![CDATA[Chemical Investigation of Some Capparis Species Growing in Egypt and their Antioxidant Activity]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>Supplement 1</prism:number>
<prism:volume>4</prism:volume>
<prism:endingPage>28</prism:endingPage>
<prism:publicationDate>2007-09-01</prism:publicationDate>
<prism:startingPage>25</prism:startingPage>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/4/suppl_1/29?rss=1">
<title><![CDATA[Aphrodisiac Activity of Dactylorhiza hatagirea (D.Don) Soo in Male Albino Rats]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/4/suppl_1/29?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Thakur, M., Dixit, V. K.]]></dc:creator>
<dc:date>2007-10-04</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem111</dc:identifier>
<dc:title><![CDATA[Aphrodisiac Activity of Dactylorhiza hatagirea (D.Don) Soo in Male Albino Rats]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>Supplement 1</prism:number>
<prism:volume>4</prism:volume>
<prism:endingPage>31</prism:endingPage>
<prism:publicationDate>2007-09-01</prism:publicationDate>
<prism:startingPage>29</prism:startingPage>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/4/suppl_1/33?rss=1">
<title><![CDATA[Academic Education in Complementary Medicine: a Tuscan Methodological Perspective]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/4/suppl_1/33?rss=1</link>
<description><![CDATA[
<p>The implementation of complementary medicine (CM) involves a large number of persons in Italy, and in the nineties, the percentage of Italian citizens adopting the most frequent and relevant practices of CM almost doubled. Appropriate academic education in CM is an important and fascinating challenge for current didactic systems in the Italian University. Already in 2004, the Joint Italian Conference of the Deans of the Faculties of Medicine and of the Presidents of Medical Degree Courses released an official statement regarding the relationship between CM and health area degree courses. The main teaching objectives embedded in the institutional framework proposed by the Joint Italian Conference are now finding specific implementation modalities in the University of Florence. For many years, the Florence Medical School has had strong and fruitful contacts with institutional bodies in Tuscany and, together with these institutions, has established a continuous dialogue with the world of CM. This exchange has given rise to various teaching activities within the academic setting. With specific reference to the undergraduate curriculum in Medicine and Surgery, a methodological course regarding CM has been designed and conducted, with selective attention being given to the CM practices having an enhanced rate of supportive scientific evidence, such as herbal medicine and acupuncture. With regard to the postgraduate curriculum, a Master degree in Acupuncture and Traditional Chinese Medicine and a Master in Clinical Phytotherapy are already active in the University of Florence and are having a remarkable success among the attending health professionals. This high degree of satisfaction well documents the importance, need and feasibility of structured academic education in CM and, in particular, of a methodological didactics such as those currently implemented in the Florence Medical School.</p>
]]></description>
<dc:creator><![CDATA[Gensini, G. F., Conti, A. A.]]></dc:creator>
<dc:date>2007-10-04</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem105</dc:identifier>
<dc:title><![CDATA[Academic Education in Complementary Medicine: a Tuscan Methodological Perspective]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>Supplement 1</prism:number>
<prism:volume>4</prism:volume>
<prism:endingPage>36</prism:endingPage>
<prism:publicationDate>2007-09-01</prism:publicationDate>
<prism:startingPage>33</prism:startingPage>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/4/suppl_1/37?rss=1">
<title><![CDATA[Herbal Medicine Today: Clinical and Research Issues]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/4/suppl_1/37?rss=1</link>
<description><![CDATA[
<p>Herbal medicine is the use of medicinal plants for prevention and treatment of diseases: it ranges from traditional and popular medicines of every country to the use of standardized and tritated herbal extracts. Generally cultural rootedness enduring and widespread use in a Traditional Medical System may indicate safety, but not efficacy of treatments, especially in herbal medicine where tradition is almost completely based on remedies containing active principles at very low and ultra low concentrations, or relying on magical-energetic principles.</p>
<p>In the age of globalization and of the so-called &lsquo;plate world&rsquo;, assessing the &lsquo;transferability&rsquo; of treatments between different cultures is not a relevant goal for clinical research, while are the assessment of efficacy and safety that should be based on the regular patterns of mainstream clinical medicine.</p>
<p>The other black box of herbal-based treatments is the lack of definite and complete information about the composition of extracts. Herbal derived remedies need a powerful and deep assessment of their pharmacological qualities and safety that actually can be realized by new biologic technologies like pharmacogenomic, metabolomic and microarray methology. Because of the large and growing use of natural derived substances in all over the world, it is not wise to rely also on the tradition or supposed millenarian beliefs; explanatory and pragmatic studies are useful and should be considered complementary in the acquisition of reliable data both for health caregiver and patients.</p>
]]></description>
<dc:creator><![CDATA[Firenzuoli, F., Gori, L.]]></dc:creator>
<dc:date>2007-10-04</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem096</dc:identifier>
<dc:title><![CDATA[Herbal Medicine Today: Clinical and Research Issues]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>Supplement 1</prism:number>
<prism:volume>4</prism:volume>
<prism:endingPage>40</prism:endingPage>
<prism:publicationDate>2007-09-01</prism:publicationDate>
<prism:startingPage>37</prism:startingPage>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/4/suppl_1/41?rss=1">
<title><![CDATA[Herbal Medicines: Can We Do Without Pharmacologist?]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/4/suppl_1/41?rss=1</link>
<description><![CDATA[
<p>The increase of herbal medicine use led many scientists to contribute to the research in this field. Also a few pharmacologists, after an initial phase of correct criticisms, today recognize the possibility of investigating the scientific value of medicinal products composed essentially of vegetable extracts. However, it is logical to pose the questions: (i) is there a role for the pharmacologist in herbal medicine (or phytotherapy)? (ii) can we do without pharmacologists&rsquo;? First, two worlds&mdash;drug researchers (pharmacologists) and herbal medicines&mdash;yesterday appearing in opposition, are today closer and it is not unusual to read scientific works describing herbal extracts in journals traditionally dedicated to the study of synthetic drugs. Second, clinical application of herbal medicines is evaluable through the methods of modern clinical pharmacology. Efficacy and safety of medicinal plants represent naturally the object of interest for the pharmacologist and it is surely this aspect which gives the most important information on herbal medicine use. Many plants have been studied and results published showing, one time good or another poor, efficacy. Safety aspects of some of the most frequently used plants are now well known. For example, today we learn to use <I>hypericum</I> and we do not give it to patients taking other drugs because the interactions of <I>hypericum</I> with them. Contraindications of other plants, often represented by interactions with drugs, are finally known (<I>Ginkgo biloba</I> and drugs acting on blood coagulation). In conclusion, antagonistic behavior of pharmacologists versus herbal medicines is not useful. On the contrary, modern phytotherapy needs the contribution of researchers usually trained to evaluate efficacy and safety of medicinals.</p>
]]></description>
<dc:creator><![CDATA[Calapai, G., Caputi, A. P.]]></dc:creator>
<dc:date>2007-10-04</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem095</dc:identifier>
<dc:title><![CDATA[Herbal Medicines: Can We Do Without Pharmacologist?]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>Supplement 1</prism:number>
<prism:volume>4</prism:volume>
<prism:endingPage>43</prism:endingPage>
<prism:publicationDate>2007-09-01</prism:publicationDate>
<prism:startingPage>41</prism:startingPage>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/4/suppl_1/45?rss=1">
<title><![CDATA[The Social Demand for a Medicine Focused on the Person: The Contribution of CAM to Healthcare and Healthgenesis]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/4/suppl_1/45?rss=1</link>
<description><![CDATA[
<p>The Non Conventional Medicines have a greater social impact and the demand for such treatments of more than 10 million Italian citizens (male and female) of all ages and social classes and of thousands of Italian families reveals an interest proving that there is a trend reversal, involving also other sectors of the medical and scientific world, which shifts the focus from the symptom to an idea of more general and comprehensive well-being of the person. Over the last few years the scientific debate on Non Conventional Medicines and their integration with the academic or dominant medicine in our western society has favored and legitimated an increase in the demand and has activated a cultural transformation process involving the life styles. The focus is therefore shifted to the self-healing capacities, to the reawakening of the individual potentialities, which support and amplify the benefits of the treatments and the citizens start pretending to be accurately informed in order to choose freely their own health program.</p>
]]></description>
<dc:creator><![CDATA[Roberti di Sarsina, P.]]></dc:creator>
<dc:date>2007-10-04</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem094</dc:identifier>
<dc:title><![CDATA[The Social Demand for a Medicine Focused on the Person: The Contribution of CAM to Healthcare and Healthgenesis]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>Supplement 1</prism:number>
<prism:volume>4</prism:volume>
<prism:endingPage>51</prism:endingPage>
<prism:publicationDate>2007-09-01</prism:publicationDate>
<prism:startingPage>45</prism:startingPage>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/4/suppl_1/53?rss=1">
<title><![CDATA[History/Philosophy]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/4/suppl_1/53?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>2007-10-04</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem112</dc:identifier>
<dc:title><![CDATA[History/Philosophy]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>Supplement 1</prism:number>
<prism:volume>4</prism:volume>
<prism:endingPage>54</prism:endingPage>
<prism:publicationDate>2007-09-01</prism:publicationDate>
<prism:startingPage>53</prism:startingPage>
<prism:section>Abstracts</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/4/suppl_1/55?rss=1">
<title><![CDATA[Basic Science]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/4/suppl_1/55?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>2007-10-04</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem117</dc:identifier>
<dc:title><![CDATA[Basic Science]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>Supplement 1</prism:number>
<prism:volume>4</prism:volume>
<prism:endingPage>58</prism:endingPage>
<prism:publicationDate>2007-09-01</prism:publicationDate>
<prism:startingPage>55</prism:startingPage>
<prism:section>Abstracts</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/4/suppl_1/59?rss=1">
<title><![CDATA[Clinical Analyses]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/4/suppl_1/59?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>2007-10-04</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem113</dc:identifier>
<dc:title><![CDATA[Clinical Analyses]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>Supplement 1</prism:number>
<prism:volume>4</prism:volume>
<prism:endingPage>64</prism:endingPage>
<prism:publicationDate>2007-09-01</prism:publicationDate>
<prism:startingPage>59</prism:startingPage>
<prism:section>Abstracts</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/4/suppl_1/65?rss=1">
<title><![CDATA[Veterinary Science/Animal Model]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/4/suppl_1/65?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>2007-10-04</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem114</dc:identifier>
<dc:title><![CDATA[Veterinary Science/Animal Model]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>Supplement 1</prism:number>
<prism:volume>4</prism:volume>
<prism:endingPage>68</prism:endingPage>
<prism:publicationDate>2007-09-01</prism:publicationDate>
<prism:startingPage>65</prism:startingPage>
<prism:section>Abstracts</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/4/suppl_1/69?rss=1">
<title><![CDATA[Policy]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/4/suppl_1/69?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>2007-10-04</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem115</dc:identifier>
<dc:title><![CDATA[Policy]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>Supplement 1</prism:number>
<prism:volume>4</prism:volume>
<prism:endingPage>70</prism:endingPage>
<prism:publicationDate>2007-09-01</prism:publicationDate>
<prism:startingPage>69</prism:startingPage>
<prism:section>Abstracts</prism:section>
</item>

</rdf:RDF>